The Event

WNIF | London

World Neuroscience Innovation Forum | 27 March 2017 | Francis Crick Institute, London, UK
Where High-Impact Global Initiatives Begin

The World Neuroscience Innovation Forum is a tailored, neuroscience gathering that builds on the broad success of the flagship Annual Forums. The Neuroscience Forum will take place in London at the Francis Crick Institute on 27 March 2017. It will feature highly-interactive exchanges among neuroscience leaders, with the aim of turning insights into action. The London Forum is being jointly hosted by Partners HealthCare and the Francis Crick Institute. It is a collaboration among them, other academic centers and leading pharmaceutical and biotechnology companies. The goal of the London Forum is to spark new insights, therapeutic paths and collaborations to combat neuroinflammation and neurodegeneration found in diseases such as Alzheimer’s and multiple sclerosis. The London Forum will convene 300 international leaders from the broad neuroscience community, including principals from the corporate, academic, government, foundation and investment sectors.

Its objectives are to:

  • Launch focused translation and commercialization collaborations to address
    unmet needs.
  • Seed new and grow world-class international neuroscience teams that will lead to
    high impact commercial products.
  • Initiate Neuroscience Innovation Planning Grant Awards designed to position
    new international commercialization-oriented teams for substantial industry,
    government and philanthropic support.
  • Increase interactions among top neuro-oriented investigators, investors,
    entrepreneurs, corporate leaders, philanthropists and government executives
    across Europe and in the US.

World Medical Innovation Forums

27–29 April 2015

CANCER  |  Boston
25–27 April 2016

27 March 2017

1–3 May 2017

The Francis Crick Institute

The Francis Crick Institute

The Francis Crick Institute is a world-leading centre of biomedical research and innovation. It will promote connections between researchers, disciplines and academic institutions and between healthcare organisations and businesses. Dedicated to research excellence, the institute will have the scale, vision and expertise to tackle the most challenging scientific questions underpinning health and disease.

The Francis Crick Institute is a charity, founded by the Medical Research Council, Cancer Research UK, The Wellcome Trust, UCL (University College London), Imperial College London and King’s College London. It will be world-class with a strong national role – training scientists and developing ideas for public good.

World Neuroscience Innovation Forum Steering Committee

Anne Klibanski, MD
Chief Academic Officer, Partners HealthCare; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, Harvard Medical School
(Forum Chair)

Paul Anderson, MD, PhD
Chief Academic Officer, Brigham and Women’s Hospital; K. Frank Austen Professor of Medicine, Harvard Medical School

Kate Bingham
Managing Partner, SVLS

Merit Cudkowicz, MD
Chair of Neurology, Massachusetts General Hospital; Julianne Dorn Professor of Neurology, Harvard Medical School

Jean-François Formela, MD
Partner, Atlas Venture

Brad Hyman, MD, PhD
Director, MGH Alzheimer's Disease Research Center, Massachusetts General Hospital; John B. Penny, Jr. Professor Neurology, Harvard Medical School

Philip Iredale
VP, Head of Circuits, Neuro-Opportunities & Screening, Technologies, Pfizer

Ole Isacson, MD, PhD
Principal Investigator Harvard Stem Cell Institute, McLean Hospital; Professor of Neurology and Neuroscience, Harvard Medical School

Husseini Manji, MD
Global Therapeutic Head, Neuroscience, Janssen R&D

John McDonald
VP, Business Development, Biogen

Harry Orf, PhD
SVP for Research, MassGeneral Research Institute, Massachusetts General Hospital

Kerry Ressler, MD, PhD
Chief Scientific Officer, McLean Hospital; Professor in Psychiatry, Harvard Medical School

David Roblin, MD
COO and Director of Scientific Translation, The Francis Crick Institute

Martin Samuels, MD
Chair, Department of Neurology, Brigham and Women’s Hospital; Miriam Sydney Joseph Professor of Neurology, Harvard Medicine School

Nadeem Sarwar, PhD
President, AiM Institute, Eisai

Dennis Selkoe, MD
Co-Director, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital; Vincent and Stellla Coates Professor of Neurologic Diseases, Harvard Medical School

David Silbersweig, MD
Chairman, Psychiatry, Brigham and Women’s Hospital; Stanley Cobb Professor of Psychiatry, Harvard Medical School

Susan Slaugenhaupt, PhD
Elizabeth G. Riley and Dan E. Smith, Jr. MGH Research Scholar, Scientific Director of the Mass General Research Institute, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Reisa Sperling, MD
Director, Center for Alzheimer's Research and Treatment, Brigham and Women’s
Hospital; Professor of Neurology, Harvard Medical School

Rudolph Tanzi, PhD
Director, Genetics and Aging Research Unit, Massachusetts General Hospital,
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital; Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School

Frank Tarazi, PhD
Director, Psychiatric Neuroscience Program, McLean Hospital; Associate Professor of Psychiatry and Neuroscience, Harvard Medical School.

Howard Weiner, MD
Director, Multiple Sclerosis Program, Brigham and Women’s Hospital;
Robert L. Kroc Professor of Neurology, Harvard Medical School